Bioporto A/S banner

Intrinsic Value

The intrinsic value of Bioporto A/S (2P4) under the Base Case is 0.082 EUR per share. Compared with the current market price of 0.1225 EUR, the stock appears Overvalued by 33% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

2P4 Intrinsic Value
€0.082
Overvaluation 33%
Intrinsic Value
Price €0.1225

2P4 is cheaper than usual. Still overvalued, but less so than on 78% of days in the past 5 years.

Monitor 2P4
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.07
Get notified when the price drops into your buy zone
Current Price €0.12
Intrinsic Value €0.08
Margin of Safety 20% €0.07
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 2P4

Fundamental Analysis

What Bioporto A/S Does

Biotechnology Health Care

BioPorto A/S develops and sells diagnostic tests and antibodies used in hospitals, laboratories, and research settings. Its main products are lab tests that help doctors detect kidney injury and related conditions by measuring specific proteins in blood or urine, with a strong focus on earlier and more accurate diagnosis than standard routine tests.

Headquarters
Denmark DK
Employees
46
IPO date
Jan 2, 1985
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bioporto A/S

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 2P4 stock?

The intrinsic value for Bioporto A/S (2P4) under the Base Case is 0.082 EUR.

Is 2P4 stock undervalued or overvalued?

Compared with the current market price of 0.1225 EUR, the stock appears Overvalued by 33% .

Back to Top